These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38026932)

  • 1. Evaluation of the impact of rifampicin on the plasma concentration of linezolid in tuberculosis co-infected patients.
    Yan P; Shi QZ; Hu YX; Zeng Y; Lu H
    Front Pharmacol; 2023; 14():1260535. PubMed ID: 38026932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Linezolid Serum Concentrations in Three Critically Ill Patients: Clinical Case Studies of a Potential Drug Interaction between Linezolid and Rifampicin.
    Blassmann U; Roehr AC; Frey OR; Koeberer A; Briegel J; Huge V; Vetter-Kerkhoff C
    Pharmacology; 2016; 98(1-2):51-5. PubMed ID: 27046487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment.
    Eimer J; Fréchet-Jachym M; Le Dû D; Caumes E; El-Helali N; Marigot-Outtandy D; Mechai F; Peytavin G; Pourcher V; Rioux C; Yazdanpanah Y; Robert J; Guglielmetti L;
    Clin Infect Dis; 2023 Feb; 76(3):e947-e956. PubMed ID: 35717636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.
    Pea F; Viale P; Cojutti P; Del Pin B; Zamparini E; Furlanut M
    J Antimicrob Chemother; 2012 Aug; 67(8):2034-42. PubMed ID: 22553142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.
    Ashizawa N; Tsuji Y; Kawago K; Higashi Y; Tashiro M; Nogami M; Gejo R; Narukawa M; Kimura T; Yamamoto Y
    J Infect Chemother; 2016 May; 22(5):331-4. PubMed ID: 26732509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China.
    Fang MT; Su YF; An HR; Zhang PZ; Deng GF; Liu HM; Mao Z; Zeng JF; Li G; Yang QT; Wang ZY
    BMC Infect Dis; 2021 Sep; 21(1):1015. PubMed ID: 34583653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
    Kawasuji H; Tsuji Y; Ogami C; Kimoto K; Ueno A; Miyajima Y; Kawago K; Sakamaki I; Yamamoto Y
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):13. PubMed ID: 33663616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis.
    Bock M; Van Hasselt JGC; Schwartz F; Wang H; Høiby N; Fuursted K; Ihlemann N; Gill S; Christiansen U; Bruun NE; Elming H; Povlsen JA; Køber L; Høfsten DE; Fosbøl EL; Pries-Heje MM; Christensen JJ; Rosenvinge FS; Torp-Pedersen C; Helweg-Larsen J; Tønder N; Iversen K; Bundgaard H; Moser C
    J Antimicrob Chemother; 2023 Dec; 78(12):2840-2848. PubMed ID: 37823408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid-related adverse effects in the treatment of rifampicin resistant tuberculosis: a retrospective study.
    Cui D; Hu X; Shi L; Wang D; Chen G
    J Chemother; 2023 Sep; 35(5):404-410. PubMed ID: 36322121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid for drug-resistant pulmonary tuberculosis.
    Singh B; Cocker D; Ryan H; Sloan DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY; Bilgin K; Uzun M; Durupinar B
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models.
    Srinivas NR; Syed M
    Drugs R D; 2016 Mar; 16(1):69-79. PubMed ID: 26747454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of high plasma concentrations of linezolid in Taiwanese adult patients- therapeutic drug monitoring in improving adverse drug reactions.
    Cheng CN; Wu CC; Kuo CH; Wang CC; Wang JT; Lin YT; Jhang RS; Lin SW
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):466-475. PubMed ID: 32600864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
    Pea F; Cojutti PG; Baraldo M
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):303-308. PubMed ID: 28419737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis.
    Ren Y; Nuttall JJ; Egbers C; Eley BS; Meyers TM; Smith PJ; Maartens G; McIlleron HM
    J Acquir Immune Defic Syndr; 2008 Apr; 47(5):566-9. PubMed ID: 18197120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone penetration of linezolid in osteoarticular tuberculosis patients of China.
    Wen S; Zhang T; Yu X; Dong W; Lan T; Fan J; Xue Y; Wang F; Dong L; Qin S; Huang H
    Int J Infect Dis; 2021 Feb; 103():364-369. PubMed ID: 33278623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection.
    Harbarth S; von Dach E; Pagani L; Macedo-Vinas M; Huttner B; Olearo F; Emonet S; Uçkay I
    J Antimicrob Chemother; 2015 Jan; 70(1):264-72. PubMed ID: 25209610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
    Mercier T; Desfontaine V; Cruchon S; Da Silva Pereira Clara JA; Briki M; Mazza-Stalder J; Kajkus A; Burger R; Suttels V; Buclin T; Opota O; Koehler N; Sanchez Carballo PM; Lange C; André P; Decosterd LA; Choong E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1211():123456. PubMed ID: 36240540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of linezolid into bone tissue 24 h after administration in patients with multidrug-resistant spinal tuberculosis.
    Li Y; Huang H; Dong W; Lan T; Fan J; Wen S; Zhang T; Qin S; Guo A
    PLoS One; 2019; 14(10):e0223391. PubMed ID: 31581274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013-2018.
    McDowell A; Haas M; Seaworth B; Wilson JW; Patrawalla A; Haley C; Lauzardo M; de Bruyn M; Goswami ND
    J Clin Tuberc Other Mycobact Dis; 2021 Feb; 22():100201. PubMed ID: 33336084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.